1. Triglyceride-rich lipoproteins are thought to be associated with an increased risk for cardiovascular disease because of which of the following:

2. Genetic variants known to be associated with decreased triglyceride-rich lipoproteins include which one of the following:

3. Restrictions on alcohol consumption by the American Heart Association (AHA) for patients with very high triglycerides indicate which of the following:

4. Which of the following drug classes should not be considered for the treatment of hypertriglyceridemia:

5. According to a review in the National Library of Medicine Herbal Supplement Database of the dietary supplement omega-3 fatty acids, the average number of product servings determined to deliver a combined dose of eicosapentaenoic acid (EPA)-docosahexaenoic acid (DHA) of 3.4 grams/day was ________.

6. Which of the following omega-3 fatty acids products has the least potential to increase LDL-C for patients with very high triglyceride levels:

7. Which classes of lipid-modifying therapy have the greatest magnitude of effect in reducing plasma triglycerides?

8. When counseling patients with hypertriglyceridemia, this population should be advised that the most common side effects of omega-3 fatty acids include which of the following:

9. The addition of which of the following non-statin therapies has been demonstrated to further reduce adverse cardiovascular risk for patients on statin therapy:

10. When prescription omega-3 fatty acids products are used to treat patients with high triglyceride levels (200 to 500 mg/dL), the average range for the decrease of plasma triglycerides is

« Return to Activity